跳转至内容
Merck

SML3532

Sigma-Aldrich

BAY-091

≥98% (HPLC)

别名:

(R)-2-(3-Cyano-2-(2′-fluoro-3′-methylbiphenyl-4-yl)-1,7-naphthyridin-4-ylamino)butanoic acid, BAY 091, BAY091

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C26H21FN4O2
分子量:
440.47
分類程式碼代碼:
12352200
NACRES:
NA.21

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: 2 mg/mL, clear

儲存溫度

2-8°C

SMILES 字串

N#CC1=C(N=C2C=NC=CC2=C1N[C@H](CC)C(O)=O)C3=CC=C(C=C3)C4=C(C(C)=CC=C4)F

生化/生理作用

BAY-091 is a potent and highly selective PIP4K2A inhibitor (IC50 = 1.3/2.6 nM with 10/250 μM [ATP] by ADP-Glo, 8.5/16.4 nM with 10 μM/2 mM [ATP] by HTRF) with good cellular permeability (target engagement EC50 = 1.1 μM/intact cells vs 1.8 μM/cell lysate by CETSA) and no significant off-target activity as assessed by a 373-kinase panel (<60% inhibition at 1 μM).

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lars Wortmann et al.
Journal of medicinal chemistry, 64(21), 15883-15911 (2021-10-27)
PIP4K2A is an insufficiently studied type II lipid kinase that catalyzes the conversion of phosphatidylinositol-5-phosphate (PI5P) into phosphatidylinositol 4,5-bisphosphate (PI4,5P2). The involvement of PIP4K2A/B in cancer has been suggested, particularly in the context of p53 mutant/null tumors. PIP4K2A/B depletion has

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门